Objective: To compare clinical rating scales of blepharospasm severity with involuntary eye closures measured automatically from patient videos with contemporary facial expression software.
vision and machine learning. It automatically finds the face and detects facial "action units" on the basis of the facial action coding system, 14 widely used for coding facial expressions in behavioral sciences. 15 In neurologically normal individuals, CERT demonstrates state-of-the-art performance, discriminating emotions in benchmark datasets 16 consisting of .100 individuals producing .500 sequences of expressions. 11, 17 We evaluated the clinical utility of CERT for measuring blepharospasm severity through 2 objectives: to test convergent validity, i.e., whether CERT measures of involuntary eye closure agree with clinical severity ratings, and to determine the viability of CERT, i.e., the proportion of video frames on which CERT can automatically find the patient's face. METHODS Patients. We evaluated patients previously recruited into the Dystonia Coalition's multicenter Natural History and Biorepository of Isolated Dystonia cross-sectional study. The biorepository includes a centralized, web-based platform for securely uploading, storing, and serving patient data, including video recordings. 18 The system meets Health Insurance Portability and Accountability Act guidelines for security and has been approved by the Human Research Protection Office at the Washington University School of Medicine (WUSM). The Human Research Protection Office at the University of California, San Diego (UCSD) also approved access to the patient data by the UCSD team, including the ability to observe streamed videos (protocol 111255X). We identified 50 patients with isolated dystonia, including at least blepharospasm with or without lower facial involvement, for subsequent analysis with CERT. Most patients were treated with botulinum toxin, with the last injection at least 2 months before the examination. Our only inclusion criterion was that the GDRS and BFM clinical severity ratings were conducted at the same visit as the video recording (for patient characteristics, see the table).
Clinical examination and severity ratings. Patients underwent a standardized clinical examination based in part on a protocol developed by the Dystonia Study Group, 7 modified to accommodate features of many types of dystonia as described by Yan et al., 18 and recorded with digital video at 30 frames per second. We extracted from the videos the part of the examination protocol focusing on blepharospasm (part I, steps 1-4). 18 The participant is seated in a chair facing the video camera. Feet are resting on the floor, and hands are resting in the lap. The camera is zoomed in to capture the head and shoulders only: (1) at rest, eyes open for 10 seconds; (2) at rest, eyes closed gently for 10 seconds; (3) at rest, after eyes are opened, for another 10 seconds; and (4) forced eyelid closure 3 times, with the effect observed for 5 seconds after each closure.
One patient was excluded from further analysis because she was noted on observation to not fully close her eyes during periods of instructed eye closure.
Patient videos were accompanied by clinical severity scores. In this study, we specifically focused on blepharospasm severity ratings and did not include "duration" factors because of the relatively short observation periods. Site ratings, normally conducted live by clinicians who were familiar with the patient's history, included the upper face item from the BFM 5,6 and GDRS. 7 Three movement disorders experts (M.H., H.J., J.P.), blinded to the live ratings, scored the videos using the BFM, GDRS, and JRS. 8 Interrater agreement was evaluated with the intraclass correlation (ICC), and then the 3 raters' video scores were averaged on each patient for each rating scale.
Computational video analysis with CERT. To mitigate security risks associated with transferring files containing video recordings of patient faces, we developed an iterative video preprocessing procedure between the Dystonia Coalition Biorepository team at WUSM and the primary analysis team at UCSD. First, at WUSM, video files were cropped to include just the relevant part of the recording and saved as a separate file that was also re-encoded for streaming. Second, the UCSD team reviewed the streamed videos to validate proper cropping. Third, the WUSM team manually segmented the videos into 9 periods of the examination protocol, 5 periods when the eyes should be open and 4 periods of instructed eye closures, using open-source video annotation software (Elan, 19 Max Planck Institute for Psycholinguistics, The Language Archive, Nijmegen, the Netherlands), saving as outputs the time stamps of each segment boundary. The WUSM team also ran the video file through CERT. Both the segment boundary time stamps and CERT outputs, without video or patient-identifying information, were sent to the UCSD team as ASCII files. Fourth, the UCSD team reviewed the Elan output files against the streamed videos to validate the segmenting process.
In this study, we used CERT version 4.4.5, previously available from UCSD for academic use and now available as FACET commercial software from iMotions.com (see the CERT processing pipeline depicted in figure 1 ). Faces were automatically located in each video frame by searching for standard facial landmarks such as eyes, nose, and mouth using previously published computer vision methods. 17, 20 We set an a priori criterion of 80% to be the minimum proportion of face-found frames for reasonable assessment of the patient's eye closure features. The raw output of CERT consisted of a continuous-valued measure of eye closure for each video frame. Because of the nature of the machine learning classifier from which it was derived, it was dimensionless and relative, with more negative values associated with open eyes and more positive with closed eyes. Downstream analysis with the CERT raw measure of eye closure included only the face-found frames and was conducted with MATLAB (The MathWorks, Inc, Natick, MA). To determine the percentage of time of eyes closed during the periods of instructed eye opening, we needed a way to declare eyes open or closed on each video frame, so we calculated an eye closure threshold for each patient. The video examination protocol included substantial periods of instructed eye closures and eye openings. For this protocol, the distributions of the CERT raw eye closure measure over time would be bimodal for neurologically normal individuals, in which case choosing a threshold between eyes open and eyes closed states would be trivial. In contrast, we hypothesized that the distribution would not be bimodal for patients with blepharospasm, so we first evaluated the distributions for bimodality using the Sarle bimodality test (see appendix e-1 at Neurology.org). In the event that .10% of the patients' eye closure distributions were not bimodal, we used a more conventional thresholding method, similar to that used by Bologna et al. 21 Specifically, we calculated the mean of the means of the lowest 5% and highest 5% of samples. Using this per-patient eye closure threshold, we calculated the percentage of time that each patient's eyes were closed when the patient was instructed to have them open, i.e., the number of video frames on which eyes are closed divided by the total number of video frames from the concatenated eyes open time segments.
Statistical analysis. Correlations were evaluated with the
Spearman rank correlation coefficient (r) with JMP (SAS Institute Inc, Cary, NC) and characterized with the Cohen effect size conventions. 22 One-sided correlation comparisons were made with Fisher z transforms of the Spearman r values, parameterized for dependent and overlapping groups (cocor, 23 comparing correlations, 1.1-2, http://comparingcorrelations.org). We used an a level of 0.05 to determine significance and 95% confidence intervals (CIs). video frames ( figure 3 ). Some exhibited clearly bimodal distributions ( figure 3A) , while others did not ( figure 3B ). On the basis of the Sarle bimodality test (see appendix e-1), a substantial portion (12 of 49, 24%) had distributions that were not bimodal ( figure 3C ). Thus, we used the conventional method for thresholding the eye closure output (see Methods). This per-patient threshold was then used to determine whether the eyes were closed on each video frame and the percentage of frames during the DISCUSSION We analyzed the CERT eye closure measures to objectively compute the percent of time that the patients' eyes were closed when the patients were instructed to open them. We found correlations between this measure and all of the clinical severity measures. Thus, the CERT eye closure measure exhibits convergent validity with conventional clinicianscored rating scales. This overarching result held across all 3 clinical rating scales used (the BFM, GDRS, and JRS), as well as the 2 modalities in which they were administered (live and from video observations).
RESULTS
The correlations between CERT and the clinical severity ratings varied slightly, depending on whether the ratings were live or based on video review. This is expected, given the moderate but imperfect correlation between the live and video-based rating modalities, a discrepancy that has been widely acknowledged 24 but not systematically investigated. There was a trend toward the CERT eye closure measure correlating better with video than live ratings, reaching significance for some but not all statistical comparisons. CERT and the video raters may detect eye closures that are missed by a live rater who may not direct complete attention to observing the patient when simultaneously recording scores. Perhaps it is more important that the video raters evaluate the same video that CERT analyzed, which may enhance convergence. CERT was robust with respect to variable head movement and variable lighting conditions during the video recording, reliably registering the face an average of 99.6% of the video frames across all patients. The lowest percentage of face-found frames, at 93%, far exceeded our a priori threshold of 80% for retaining videos for further analysis. This is particularly encouraging for the relevance of CERT for patients with cranial dystonia with or without comorbid cervical dystonia because about one-fourth of the patients in this study also had head tremor. It also supports the broader applicability of CERT for analyzing video recordings from a conventional clinical setting because no special efforts were made to optimize lighting conditions in the present study.
The present study has a few noteworthy limitations. First, severity is not uniformly distributed. In the case of the GDRS, for example, the preponderance of patients were rated 3 to 4, with relatively few rated in the 1 to 2 and 8 to 10 ranges. Although this likely represents the larger population of patients diagnosed with blepharospasm, it diminishes our ability to test convergent validity among rating methods at the low and high extremes of severity. Post hoc review of the 2 notable outliers, patients with 80% and 78% eye closure, suggests that these were legitimate measures of severe blepharospasm and not CERT processing artifacts. This emphasizes limitations in the linearity of the clinical rating scales at the high end. Second, the present study included 49 patients. A larger cohort may increase statistical power and include more severe patients, depending on the distribution in the population and any sampling bias. Third, the video observation period may be too brief, potentially providing insufficient duration of instructed eyes open periods to permit detection of low but still pathologic amounts of eye closure. The floor effect apparent in the distributions of the CERT eye closure measure (see figure 4) , in which several patients exhibited little if any eye closure during the instructed eyes open periods, supports this possibility. In this study, the cumulative duration of instructed eyes open periods averaged 43 seconds, whereas other studies used 120 seconds of video to evaluate blink rate in blepharospasm. 25, 26 Nevertheless, the brief instructed eye open periods in the present study were the same for CERT and for the video reviewers, so both approaches had the same data on which to base their analyses. Indeed, briefer observation periods, if sufficient to assay severity, could contribute to clinical efficiency. All 3 of these limitations could be addressed by CERT application to a larger study incorporating a broader distribution of severity and longer observation periods.
Our results further highlight concerns about the reliability of inherently subjective methods for evaluating blepharospasm severity and support the need for more objective measures of motor symptoms in dystonia. 4, 27 The 3 video reviewers, after conducting a joint practice session to work toward consensus on how to apply the rating scales immediately before their independent ratings, exhibited only moderate agreement (ICC z0.6) on the severity ratings across these patients. The video raters also exhibited only moderate correlation (Spearman r 5 0.58-0.61) with the live raters. These interrater results are consistent with those of previous reports using the BFM and GDRS for blepharospasm. 7 Objective measures can mitigate the intrarater and interrater confounds inherent in human assessments. Indeed, deterministic algorithms such as the CERT eye closure measure give intrarater and interrater variability of zero. Regardless, no gold standard for comparison exists for any of these measures. This is a concern for future rating scale development, whether based on human subjective ratings or automated objective ratings. We expect that increased integration between clinical and computational experts will provide stronger measures than either approach in isolation.
As used in the present study, CERT provides a partially automated means for assessing symptom severity in blepharospasm. Further automation could greatly alleviate the labor-intensive nature of humanbased video review, which can be tedious and error prone and can require the valuable and limited resource of blepharospasm experts. The core CERT algorithm can already be used in a real-time mode. Automating the input and output processes would enable a real-time, end-to-end video processing capability. This would facilitate the translation of CERT from research to routine clinical use. Although the focus of the present study was severity, future studies including a healthy control group could be conducted to see whether the CERT measures could reliably detect the presence of blepharospasm. Thus, future development of CERT could include an Internetbased service to provide objective screening and severity measures in near-real time while complying with appropriate Health Insurance Portability and Accountability Act and Institutional Review Board requirements.
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